...
机译:预治疗血清水平可溶性编程细胞死亡 - 配体1预测乙型肝炎相关肝细胞癌患者的预后
Sun Yat Sen Univ Canc Ctr State Key Lab Oncol South China Guangzhou 510060 Guangdong Peoples R;
Sun Yat Sen Univ Canc Ctr State Key Lab Oncol South China Guangzhou 510060 Guangdong Peoples R;
Sun Yat Sen Univ Canc Ctr State Key Lab Oncol South China Guangzhou 510060 Guangdong Peoples R;
Sun Yat Sen Univ Canc Ctr State Key Lab Oncol South China Guangzhou 510060 Guangdong Peoples R;
Sun Yat Sen Univ Canc Ctr State Key Lab Oncol South China Guangzhou 510060 Guangdong Peoples R;
Sun Yat Sen Univ Canc Ctr State Key Lab Oncol South China Guangzhou 510060 Guangdong Peoples R;
Sun Yat Sen Univ Canc Ctr State Key Lab Oncol South China Guangzhou 510060 Guangdong Peoples R;
Sun Yat Sen Univ Canc Ctr State Key Lab Oncol South China Guangzhou 510060 Guangdong Peoples R;
Sun Yat Sen Univ Canc Ctr State Key Lab Oncol South China Guangzhou 510060 Guangdong Peoples R;
HBV-related hepatocellular carcinoma; Hepatitis B virus; PD-L1; Prognosis; Soluble PD-L1;
机译:预治疗血清水平可溶性编程细胞死亡 - 配体1预测乙型肝炎相关肝细胞癌患者的预后
机译:高水平的可溶性程序性死亡配体(sPD-L1)可确定预后不良的肝细胞癌患者
机译:埃及丙型肝炎病毒基因型4的患者血清可溶性Fas,可溶性肿瘤坏死因子受体II,白介素2受体和白介素8水平是肝细胞癌的早期预测指标
机译:慢性丙型肝炎患者的BERATROPHIN表达:是否有助于肝损伤链接代谢综合征和肝细胞癌发育?
机译:质子治疗后血清α甲胎蛋白和维生素K拮抗剂II水平诱导的蛋白的短暂增加不一定表明肝细胞癌的进展
机译:肝细胞癌患者血清可溶性程序性死亡蛋白1(sPD-1)和可溶性程序性死亡配体1(sPD-L1)的相关性及预后价值
机译:肝细胞癌患者中可溶性编程死亡蛋白1(SPD-1)和可溶性编程死亡 - 配体1(SPD-L1)血清水平的相关性和预测值